AMRN Amarin Corporation plc

19.87
+2.44  (+14%)
Previous Close 17.43
Open 17.65
Price To Book -86.39
Market Cap 6483349495
Shares 326,288,349
Volume 28,576,871
Short Ratio
Av. Daily Volume 7,325,593

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

sNDA filing due late 1Q 2019. New data due March 18, 2019 at ACC.
Vascepa REDUCE-IT outcomes trial
High Triglycerides With Mixed Dyslipidemia

Latest News

  1. AMARIN CORPORATION INVESTOR ALERT: Gibbs Law Group Files Class Action Lawsuit Alleging Violations of Federal Securities Laws
  2. FDA Events Can Send Stocks Soaring: Here's One That Absolutely No One Is Talking About
  3. MNOV: Continuing to Plan for Phase 3 Studies in Progressive MS and ALS…
  4. Biotech Bounce Just Getting Started
  5. Trading Notes for Select Stocks
  6. Amarin To Report Fourth Quarter and Full Year 2018 Results and Host Conference Call on February 27, 2019
  7. What's in the Cards for Amarin (AMRN) This Earnings Season?
  8. 2 Healthcare Stocks Ripe for a Takeover
  9. Amarin (AMRN) Gains As Market Dips: What You Should Know
  10. Biotech Hedge Fund Bailed on Drugmaker Before Its Depression Treatment Scored
  11. Amarin to Present at the 8th Annual SVB Leerink Global Healthcare Conference
  12. Amarin (AMRN) Stock Moves -0.49%: What You Should Know
  13. Why Amarin Stock Jumped 29% in January After Soaring 239% Last Year
  14. Analysis: Positioning to Benefit within Amarin, Retrophin, Sunrun, BioSpecifics Technologies, Arbutus Biopharma, and TOCAGEN INC — Research Highlights Growth, Revenue, and Consolidated Results
  15. Pharma Catches Another Case Of M&A Fever
  16. The Biggest Biotech Binary Event in 2019 Is Just Around the Corner
  17. Today's Research Reports on Trending Tickers: Amarin and Celgene
  18. Why Short-Sellers Raised Their Bets Against 2 Surging Biotech Stocks
  19. Do Options Traders Know Something About Amarin (AMRN) Stock We Don't?
  20. 3 Stocks That Are Absurdly Cheap Right Now